<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02456792</url>
  </required_header>
  <id_info>
    <org_study_id>AG1</org_study_id>
    <nct_id>NCT02456792</nct_id>
  </id_info>
  <brief_title>IVF Versus LOD in Women With CC Resistant PCOS</brief_title>
  <official_title>In Vitro Fertilization Versus Laparoscopic Ovarian Drilling in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohamed Sayed Abdelhafez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy of in vitro fertilization (IVF) versus
      laparoscopic ovarian drilling (LOD) in infertile women having clomiphene citrate (CC)
      resistant polycystic ovarian syndrome (PCOS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women will be randomly divided into two groups; IVF group and LOD group. Women in the IVF
      group will undergo one full IVF cycle. Women in the LOD group will be subjected to LOD
      followed by ovarian stimulation if spontaneous ovulation does not occur within 2 months.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>9 months</time_frame>
    <description>Number of live births divided by the number of women</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>6-8 weeks gestational age</time_frame>
    <description>Number of clinical pregnancies divided by the number of women</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multifetal pregnancy rate</measure>
    <time_frame>12 weeks gestational age</time_frame>
    <description>Number of multifetal pregnancies divided by the number of clinical pregnancies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Miscarriage rate</measure>
    <time_frame>12 weeks gestational age</time_frame>
    <description>Number of first trimester miscarriages (before 12 weeks gestational age) divided by the number of clinical pregnancies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of early ovarian hyperstimulation syndrome (OHSS)</measure>
    <time_frame>Within 9 days of final triggering of oocyte maturation</time_frame>
    <description>Incidence of OHSS within 9 days of final triggering of oocyte maturation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Infertility</condition>
  <condition>Polycystic Ovarian Syndrome</condition>
  <arm_group>
    <arm_group_label>IVF group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women will undergo one full IVF cycle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LOD group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women will be subjected to LOD followed by ovarian stimulation if spontaneous ovulation does not occur within 2 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IVF</intervention_name>
    <description>Women will undergo one IVF cycle</description>
    <arm_group_label>IVF group</arm_group_label>
    <other_name>Intracytoplasmic sperm injection (ICSI)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LOD</intervention_name>
    <description>Women will be subjected to LOD followed by ovarian stimulation if spontaneous ovulation does not occur within 2 months</description>
    <arm_group_label>LOD group</arm_group_label>
    <other_name>Laparoscopic ovarian diathermy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infertile women with PCOS as defined by the Rotterdam criteria.

          -  CC resistance (defined as failure of ovulation after receiving 150 mg/day of CC for 5
             consecutive days per cycle, for at least 3 consecutive cycles).

        Exclusion Criteria:

          -  Age &lt; 20 or &gt; 35 years.

          -  Presence of any infertility factor other than anovulatory PCOS.

          -  Previous history of ovarian surgery or surgical removal of one ovary.

          -  Previous exposure to cytotoxic drugs or pelvic irradiation.

          -  Oral hypoglycemic or hormonal therapy either currently or in the preceding 3 months.

          -  Metabolic or hormonal abnormalities.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Gibreel, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed S Abdelhafez, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fertility Care Unit (FCU) in Mansoura University Hospital</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private fertility care centers</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2015</study_first_submitted>
  <study_first_submitted_qc>May 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2015</study_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mohamed Sayed Abdelhafez</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>PCOS</keyword>
  <keyword>Clomiphene citrate resistant</keyword>
  <keyword>LOD</keyword>
  <keyword>IVF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

